glp-1 receptor agonist type 1 diabetes randomized trial SGLT2i and RA therapy in and reno-vascular outcomes: a real-world study | Diabetologia GLP-1 receptor agonists and next-generation

Insulin resistance exacerbated pathological PD features which contributed to disease progression via increases in -synuclein accumulation in dopaminergic neurons, oxidative stress, and mitochondrial dysfunction

This post covers what the Bridge is, who qualifies, how it interacts with Medicares existing GLP-1 coverage for cardiovascular risk reduction, and how it connects to the previously-announced BALANCE Model

Structured exercise, adequate sleep, and targeted use of probiotics and selected nutraceuticals provide additional, evidence-informed levers to complement pharmacological GLP-1RAs or to support metabolic health in individuals who are not using these medications

The cancer metabolic reprogramming and immune response

Frontiers in pharmacology

How Reduced Outdoor Activity During Monsoon Affects Children's Immunity, Weight & Mental Health Home Health Wellness Eli Lillys Experimental Glp 1 Pill Shows Promising Weight Loss